| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/11/2006 | EP0954321B1 Synergistic compositions containing gold and a corticosteroid |
| 01/11/2006 | EP0766569B1 Aav capsid vehicles for molecular transfer |
| 01/11/2006 | CN1720064A Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 01/11/2006 | CN1720057A Chinese patent medicine for treating baldness and preparing process thereof |
| 01/11/2006 | CN1720049A Therapeutic applications of 2-substituted 4-heteroarylpyrimidines |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720029A Alpha-2-delta ligand to treat lower urinary tract symptoms |
| 01/11/2006 | CN1718711A Coluorless transparent female face beautifying wine and its preparation method |
| 01/11/2006 | CN1718244A Activated carbon external application antiphlogistine, and its prepn. method |
| 01/11/2006 | CN1718226A Medicine composition for treating leuconychia, and its prepn. method |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235644C Preparing process of antibacterial nanometer silver powder contained externally applied dressing |
| 01/11/2006 | CN1235618C Chinese-medicinal aqueogel for treating burn and its preparing process |
| 01/11/2006 | CN1235617C Skin lightening composition containing magnesium ascorbyl phosphate and uniontan-U34 TM (extract formulation of cucumber extract and lemon extract) |
| 01/11/2006 | CN1235607C Ointment for treating wound sore and its preparation method |
| 01/11/2006 | CN1235599C Arsenic compound recipe for treating tuberculosis and dermatopathy |
| 01/11/2006 | CN1235597C Wound nursing medicinal composition |
| 01/11/2006 | CN1235590C Phenasteroid gel preparation |
| 01/11/2006 | CN1235578C Fumaric acid microtablets |
| 01/11/2006 | CN1235567C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 01/11/2006 | CN1235565C Hair growing preparation containing compound of Chinese medicine and Western medicine |
| 01/11/2006 | CN1235559C Improvement of moisture retention ability of skin |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984621 Wound contraction inhibitor |
| 01/10/2006 | US6984391 Mixture containing ammonium salt; gradient adjustment of pH; skin disorders, acne |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2351620C Nano-emulsion of 5-aminolevulinic acid |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/07/2006 | CA2511642A1 Compositions containing anti-acne agents and the use thereof |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003988 Compounds capable of inhibiting immunocyte-related allergic immune reactions |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003973 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003932 Method for promoting neovascularization |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003919 Cosmetic/dermatological applications of LIF |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060002910 Agent for the anti-adhesion of skin pathogenic flora |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | CA2571444A1 Compositions for topical treatment |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570754A1 Use of targeted oxidative therapeutic formulation in treatment of burns |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1612215A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/04/2006 | EP1612201A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound |
| 01/04/2006 | EP1611892A2 Pharmaceutical compositions comprising drospirenone |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611124A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
| 01/04/2006 | EP1611086A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 01/04/2006 | EP1397153A4 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1242403B1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 01/04/2006 | EP1223950B1 Ribozyme therapy for the treatment of proliferative eye diseases |
| 01/04/2006 | EP1214081B1 Superoxidized water based on hypochlorous acid for the treatment of wounds |
| 01/04/2006 | EP1178834B1 Controlled release of growth factors from heparin containing matrices |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP1128844B1 Botulinum toxins for enhancing wound healing |
| 01/04/2006 | EP1083898B1 Novel use of hiv protease inhibiting compounds |
| 01/04/2006 | CN1717243A Papaya puree and the use of the same |
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1714869A Anhydrous topical skin preparations |
| 01/04/2006 | CN1714855A Chinese herbal medicine for treating cloasma and freckle |
| 01/04/2006 | CN1714848A Medicine for treating smelly foot and its preparing method |
| 01/04/2006 | CN1714846A Health medicinal wine for traumatic injury |
| 01/04/2006 | CN1714845A Medicinal wine for treating bite by centipede |
| 01/04/2006 | CN1714840A Chinese medicine composition for stopping itching and its preparing method |
| 01/04/2006 | CN1714838A Medical gel and its preparing method and device |
| 01/04/2006 | CN1714835A Chinese herbal medicine for treating acne and fester |
| 01/04/2006 | CN1714813A Chinese medicine preparation for preventing and treating beri-beri |
| 01/04/2006 | CN1714809A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714783A Implantable particles for tissue bulking and the treatment |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234429C Artificial skin, preparing method and application thereof |